Suggestion de sujets dans votre recherche.
Résultat(s) 1 - 11 résultats de 11 pour la requête '', Temps de recherche: 4,88s Affiner les résultats
  1. 1
    Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil Differential neutralization of SARS-CoV-2 omicron variants

    Article en ligne

  2. 2
    The type of the first prime/boost vaccine against SARS-CoV-2 exerts long-term effects on the humoral immune response

    Article en ligne

  3. 3
    Tracking the immune response profiles elicited by the BNT162b2 vaccine in COVID-19 unexperienced and experienced individuals

    Article en ligne

  4. 4
    A global survey in the developmental landscape of possible vaccination strategies for COVID-19

    Article en ligne

  5. 5
    Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine

    Article en ligne

  6. 6
    Detection of immunoglobulin response to COVID-19 vaccination using a novel rapid fingerstick assay

    Article en ligne

  7. 7
    Novel T cell interferon gamma release assay (IGRA) using spike recombinant protein for COVID19 vaccine response and Nucleocapsid for SARS-Cov2 response

    Article en ligne

  8. 8
    Immunogenicity and reactogenicity of homologous mRNA-based and vector-based SARS-CoV-2 vaccine regimens in patients receiving maintenance dialysis

    Article en ligne

  9. 9
    Reactogenicity of a third BNT162b2 mRNA COVID-19 vaccine among immunocompromised individuals and seniors - A nationwide survey

    Article en ligne

  10. 10
    Adult-onset Still's disease following mRNA COVID-19 vaccination

    Article en ligne

  11. 11
    Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico A nationwide descriptive study

    Article en ligne

Outils de recherche: S'abonner aux flux RSS — Envoyer cette recherche par courriel